Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund accounts for 14 tracked companies with verified cap-table data, 14 of which disclose round sizes totalling $1B. The median disclosed raise is $69M, and the largest is Ronovo Surgical at $211M, ahead of Cardior Pharmaceuticals ($94M) and Rgenta Therapeutics ($90M).

The names that recur most often on these portfolio cap tables are Boehringer Ingelheim Venture Fund (14 companies), AMR Action Fund (4 companies), Vivo Capital (2 companies), Matrix Partners China (2 companies), BioMedPartners (2 companies), Delos Capital (2 companies). By latest disclosed round, the market skews Series B (7), Series A (5), Series D (1), Series C (1).

• Companies tracked: 14
• Disclosed funding total: $1B across 14 companies
• Median disclosed raise: $69M
• Largest raise: Ronovo Surgical — $211M
• Stage mix: Series B 7 · Series A 5 · Series D 1 · Series C 1
• Most recent dated round: 2025-09-05

Best funded Boehringer Ingelheim Venture Fund companies

1. Ronovo Surgical — $211M (latest: Series D)
2. Cardior Pharmaceuticals — $94M (latest: Series B)
3. Rgenta Therapeutics — $90M (latest: Series A)
4. Elion Therapeutics — $81M (latest: Series B)
5. NBE-Therapeutics — $79M (latest: Series A)
6. OncoMyx Therapeutics — $75M (latest: Series B)
7. Nuevocor — $69M (latest: Series B)
8. Brainomix — $68M (latest: Series C)
9. Actym Therapeutics, Inc. — $60M (latest: Series A)
10. Aignostics — $54M (latest: Series B)
11. Otto — $48M (latest: Series B)
12. Centauri Therapeutics — $38M (latest: Series A)
13. DiogenX — $35M (latest: Series A)
14. Hookipa Pharma — $30M (latest: Series B)

Boehringer Ingelheim Venture Fund — related firms and companies (56)

• Ronovo Surgical
• Cardior Pharmaceuticals
• Rgenta Therapeutics
• Elion Therapeutics
• NBE-Therapeutics
• OncoMyx Therapeutics
• Nuevocor
• Brainomix
• Investors like Gaingels
• Investors like Ridge Ventures
• Investors like Blockchain Capital
• Investors like Fika Ventures
• Investors like Amino Capital
• Investors like Venrock
• Investors like ACME Capital
• Boehringer Ingelheim Venture Fund co-investors 2026
• Investors like Uncork Capital
• Aignostics
• Investors like Canaan Partners
• Investors like Bain Capital
• Investors like Coinbase
• Investors like BoxGroup
• Investors like Next47
• Investors like Salesforce Ventures
• Companies backed by Boehringer Ingelheim Venture Fund
• Investors like Point72 Ventures
• Centauri Therapeutics
• Investors like Atlas Venture
• Investors like Crossbeam Venture Partners
• Investors like Slow Ventures
• Investors like Flybridge
• Investors like Balderton Capital
• Investors like Mayfield Fund
• Investors like Shasta Ventures
• Investors like Expansion Venture Capital
• Hookipa Pharma
• Investors like Primary Venture Partners
• Actym Therapeutics, Inc.
• Investors like Notable Capital
• Investors like Storm Ventures
• Investors like Matrix
• Investors like Floodgate
• Investors like Bessemer Venture Partners
• Investors like Bain Capital Ventures
• Investors like Boehringer Ingelheim Venture Fund
• Investors like Bienville Capital
• Otto
• Investors like StepStone Group
• Investors like Forerunner
• Investors like Western Technology Investment
• Investors like Script Capital
• Investors like Headline
• Investors like RRE Ventures
• Investors like Alumni Ventures
• Investors like Upfront Ventures
• DiogenX

Boehringer Ingelheim Venture Fund alternatives · All research reports